EA202092107A1 - Derivatives of Cyclized Sulfamoylarylamide and Their Use as Medicines for the Treatment of Hepatitis B - Google Patents

Derivatives of Cyclized Sulfamoylarylamide and Their Use as Medicines for the Treatment of Hepatitis B

Info

Publication number
EA202092107A1
EA202092107A1 EA202092107A EA202092107A EA202092107A1 EA 202092107 A1 EA202092107 A1 EA 202092107A1 EA 202092107 A EA202092107 A EA 202092107A EA 202092107 A EA202092107 A EA 202092107A EA 202092107 A1 EA202092107 A1 EA 202092107A1
Authority
EA
Eurasian Patent Office
Prior art keywords
hepatitis
medicines
derivatives
treatment
hbv
Prior art date
Application number
EA202092107A
Other languages
Russian (ru)
Inventor
Сандрин Мари Элен Вендевилль
Стефан Жюльен Ласт
Самюэль Доминик Демэн
Сандрин Селин Гросс
Жервен Ивонн Поль Аше
Лили Ху
Серж Мария Алоисиус Питерс
Герт Ромбу
Коэн Вандик
Вим Гастон Версхюэрен
Пьер Жан-Мари Бернар Рабуассон
Original Assignee
Янссен Сайенсиз Айрлэнд Юси
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Янссен Сайенсиз Айрлэнд Юси filed Critical Янссен Сайенсиз Айрлэнд Юси
Publication of EA202092107A1 publication Critical patent/EA202092107A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D291/00—Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms
    • C07D291/08—Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/20—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D515/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D515/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D515/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D515/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D515/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D515/20—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Ингибиторы репликации HBV формулы (I-A), в том числе их стереохимически изомерные формы, а также их соли, гидраты, сольваты, где Ra-Rd и R1-R8 имеют значения, определенные в настоящем документе. Настоящее изобретение также относится к способам получения указанных соединений, содержащим их фармацевтическим композициям, а также к их применению отдельно или в комбинации с другими ингибиторами HBV в терапии инфекции HBV.HBV replication inhibitors of formula (I-A), including their stereochemically isomeric forms, as well as their salts, hydrates, solvates, where Ra-Rd and R1-R8 are as defined herein. The present invention also relates to methods for preparing said compounds, pharmaceutical compositions containing them, and their use alone or in combination with other HBV inhibitors in the therapy of HBV infection.

EA202092107A 2016-02-26 2016-07-01 Derivatives of Cyclized Sulfamoylarylamide and Their Use as Medicines for the Treatment of Hepatitis B EA202092107A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP16157726 2016-02-26

Publications (1)

Publication Number Publication Date
EA202092107A1 true EA202092107A1 (en) 2020-11-27

Family

ID=55442740

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202092107A EA202092107A1 (en) 2016-02-26 2016-07-01 Derivatives of Cyclized Sulfamoylarylamide and Their Use as Medicines for the Treatment of Hepatitis B

Country Status (1)

Country Link
EA (1) EA202092107A1 (en)

Similar Documents

Publication Publication Date Title
EA201890200A1 (en) DERIVATIVES OF CYCLIZED SULFAMOILARILAMIDE AND THEIR APPLICATION AS A MEDICINE PREPARATION FOR THE TREATMENT OF HEPATITIS B
EA201592200A1 (en) DERIVATIVES OF SULFAMOILPYRROLAMIDE AND THEIR APPLICATION AS MEDICINES FOR THE TREATMENT OF HEPATITIS B
EA201691579A1 (en) DERIVATIVES OF SULFAMOILPYRROLAMIDE AND THEIR APPLICATION AS MEDICINES FOR THE TREATMENT OF HEPATITIS B
EA201690277A1 (en) DERIVATIVES OF GLYOXAMID FAMILIATED PYRROLAMIDE AND THEIR APPLICATION AS A MEDICINAL MEANS TO TREAT HEPATITIS B
EA201991399A1 (en) AMINOTRIAZOLOPYRIDINE COMPOUNDS AND THEIR APPLICATION IN TREATMENT OF CANCER
EA201690760A1 (en) DERIVATIVES OF CARBOXAMIDE AND THEIR USE AS MEDICINES FOR THE TREATMENT OF HEPATITIS B
EA201591890A1 (en) DERIVATIVES N-PHENYLCARBOXAMIDE AND THEIR USE AS A MEDICINE PREPARATION FOR THE TREATMENT OF HEPATITIS B
EA201591586A1 (en) SULFAMOIL-ARYLAMIDE AND THEIR APPLICATION AS A MEDICINE DRUG FOR THE TREATMENT OF HEPATITIS B
EA201592198A1 (en) DERIVATIVES OF SULFAMOILTHIOPHENAMIDE AND THEIR APPLICATION AS MEDICINES FOR THE TREATMENT OF HEPATITIS B
EA201590457A1 (en) SULFAMOIL-Arylamides and Their Use as Medicinal Products for the Treatment of Hepatitis B
EA201590453A1 (en) CONDENSED BICYCLIC DERIVATIVES OF SULFAMOIL AND THEIR APPLICATION AS A MEDICINE PREPARATION FOR THE TREATMENT OF HEPATITIS B
CY1122792T1 (en) MONO-OR DISUBTITUTED INDOLE DERIVATIVES AS DANGE VIRUS REPLICATION INHIBITORS
EA201790389A1 (en) PYRROPYRIMIDINE COMPOUNDS USED AS AN AGLIST TLR7
EA201791256A1 (en) HINAZOLIN DERIVATIVES USED FOR HIV TREATMENT
EA201891063A1 (en) DERIVATIVES OF DIHYDROIMIDAZOPIRAZINONE APPLICABLE IN THE TREATMENT OF CANCER
EA201892219A1 (en) SUBSTITUTED INDIN DERIVATIVES AS AN INHIBITORS OF DENG VIRUS REPLICATION
EA201892216A1 (en) SUBSTITUTED INDIN DERIVATIVES AS AN INHIBITORS OF DENG VIRUS REPLICATION
EA201592126A1 (en) 6-BRIDGED HETEROARYDYDYDROPYRIMIDIDES FOR THE TREATMENT AND PREVENTION OF HEPATITIS B VIRUS INFECTION
EA201892214A1 (en) SUBSTITUTED DERIVATIVES OF INDOL AS AN INHIBITORS OF DENG VIRUS REPLICATION
EA201790700A1 (en) MONO OR DESIGNED INDOLS AS AN INHIBITORS REPLICATION OF DENG VIRUSES
UY36257A (en) "IMIDAZOPIRIDAZINE COMPOUNDS".
EA201792057A1 (en) CONDENSED BICYCLIC HETEROYARIL DERIVATIVES WITH ACTIVITY OF PROHYLDROXYLASE INHIBITORS
CR20180091A (en) 5- (N-BENCIL-TETRAHYDROISOQUINOLIN-6-IL) -PIRIDIN-3-IL ACETIC AS INHIBITORS OF HIV REPLICATION
EA201591456A1 (en) MACROCYCLIC AND BICYCLIC INHIBITORS OF HEPATITIS C VIRUS
EA202092107A1 (en) Derivatives of Cyclized Sulfamoylarylamide and Their Use as Medicines for the Treatment of Hepatitis B